51
Views
15
CrossRef citations to date
0
Altmetric
Article

Prolonged signal‐averaged P wave duration after elective cardioversion increases the risk of recurrent atrial fibrillation

, , , , &
Pages 147-151 | Received 02 Dec 2003, Accepted 02 Feb 2004, Published online: 12 Jul 2009

References

  • Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998; 82: 2N–9N.
  • Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. Eur Heart J 2001; 22: 693–701.
  • Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen a Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thrombo-embolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989; 1: 175–179.
  • Fuster V. Ryden LE, Asinger RW, et al. ACC/ARA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001; 22: 1852–1923.
  • Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103: 769–777.
  • Stafford PJ, Robinson D, Vincent R Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation. Br Heart J 1995; 74: 413–418.
  • Kuhlkamp V, Haasis R, Seipel L. Atrial vulnerability and electrophysiology determined in patients with and without paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1992; 15: 71–80.
  • Guidera SA, Steinberg JS. The signal-averaged P wave duration: A rapid and noninvasive marker of risk of atrial fibrillation. J Am Coll Cardiol 1993; 21: 1645–1651.
  • Ishimoto N, Ito M, Kinoshita M. Signal-averaged P-wave abnormalities and atrial size in patients with and without idiopathic paroxysmal atrial fibrillation. Am Heart J 2000; 139: 684–689.
  • Klein M, Evans SJ, Blumberg S, Cataldo L, Bodenheimer MM. Use of P-wave-triggered, P-wave signal-averaged electrocardiogram to predict atrial fibril-lation after coronary artery bypass surgery. Am Heart J 1995; 129: 895–90L
  • Dixen U, Wallevik L, Hansen MS, et al. Prolonged signal-averaged P wave duration as a prognostic marker for morbidity and mortality in patients with congestive heart failure. Scand Cardiovasc J 2003; 37: 193–198.
  • Yamada T, Fukunami M, Shimonagata T, et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: A prospective study. J Am Coll Cardiol 2000; 35: 405–413.
  • Stafford R The signal averaged P wave - out of the back room? Eur Heart J 1999; 20: 171–173.
  • Sanfilippo AJ, Abascal VM, Sheehan M, et al. Atrial enlargement as a con-sequence of atrial fibrillation. A prospective echocardiographic study. Circulation 1990; 82: 792–797.
  • Thijssen VL, Ausma J, Liu GS, Allessie MA, van Eys GJ, Borgers M Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol 2000; 9: 17–28.
  • Abe Y, Fukunami M, Yamada T, et al. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: A prospective study. Circulation 1997; 96: 2612–2616.
  • Aytemir K, Aksoyek S, Yildirir A, Ozer N, Oto A. Prediction of atrial fibrillation recurrence after cardioversion by P wave signal-averaged electro-cardiography. Int J Cardiol 1999; 70: 15–2L
  • Opolski G, Scislo P. Stanislawska J, Gorecki A, Steckiewicz R, Torbicki A. Detection of patients at risk for recurrence of atrial fibrillation after successful electrical cardioversion by signal-averaged P-wave ECG. Int J Cardiol 1997; 60: 181–185.
  • Raitt MH, Ingram KD, Thurman SM. Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversion. Pacing Clin Electrophysiol 2000; 23: 259–265.
  • Stafford PJ, Cooper J, de Bono DP, Vincent R, Garratt CJ. Effect of low dose sotalol on the signal averaged P wave in patients with paroxysmal atrial fibrillation. Br Heart J 1995; 74: 636–640.
  • Banasiak W, Telichowski A, Anker SD, et al. Effects of amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paro-xysmal atrial fibrillation and coronary artery disease. Am J Cardiol 1999; 83: 112-114, A9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.